Early progression of disease as a predictor of survival in chronic lymphocytic leukemia

Chemoimmunotherapy for chronic lymphocytic leukemia (CLL) promotes clonal evolution of aggressive clones, which in some patients may lead to early progression of disease (POD). We studied the prognostic value of early POD in a cohort of patients with CLL enrolled between 2010 and 2014 in the Connect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Ahn, Inhye E., Farber, Charles M., Davids, Matthew S., Grinblatt, David L., Kay, Neil E., Lamanna, Nicole, Mato, Anthony, Nabhan, Chadi, Kiselev, Pavel, Swern, Arlene S., Flick, E. Dawn, Sullivan, Kristen, Sharman, Jeff P., Flowers, Christopher R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729627/
https://ncbi.nlm.nih.gov/pubmed/29296893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017011262
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados